The newly engineered monoclonal antibody ON104, targeting the oxidized Macrophage Migration Inhibitory Factor (oxMIF), ameliorates clinical and histopathological signs of collagen-induced arthritis-Reference-Cited by-同舟云学术

The newly engineered monoclonal antibody ON104, targeting the oxidized Macrophage Migration Inhibitory Factor (oxMIF), ameliorates clinical and histopathological signs of collagen-induced arthritis

Published:2023-10 Issue: Volume:956 Page:175997
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Ferhat Maroua,Mangano Katia,Mirkina Irina^ORCID,Mayer Julia^ORCID,Rossmueller Gregor^ORCID,Schinagl Alexander^ORCID,Kerschbaumer Randolf,Nicoletti Ferdinando,Thiele Michael,Landlinger Christine

Publisher

Elsevier BV

Subject

Pharmacology

Reference61 articles.

1. Associations between circulating macrophage migration inhibitory factor (MIF) levels and rheumatoid arthritis, and between MIF gene polymorphisms and disease susceptibility: a meta-analysis;Bae;Postgrad. Med.,2018

2. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis;Baugh;Gene Immun.,2002

3. Arthritis models: usefulness and interpretation;Bessis;Semin. Immunopathol.,2017

4. Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic Lupus Erythematosus;Bilsborrow;Expert Opin. Ther. Targets,2019

5. MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development;Bloom;Expert Opin. Ther. Targets,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Redox-dependent plasticity of oxMIF facilitates its interaction with CD74 and therapeutic antibodies;Redox Biology;2024-09

2. Pretargeted Radioimmunotherapy with the Novel Anti-oxMIF/HSG Bispecific Antibody ON105 Results in Significant Tumor Regression in Murine Models of Cancer;Molecular Cancer Therapeutics;2024-07-04

3. Elevated MIF identified by multiple cytokine analyses facilitates macrophage M2 polarization contributing to postoperative recurrence in chronic rhinosinusitis with nasal polyps;Rhinology Journal;2024-02-01

4. Macrophage migration inhibitory factor as a therapeutic target in neuro-oncology: A review;Neuro-Oncology Advances;2024-01-01